Arcturus Therapeutics Holdings Inc (ARCT)

06:50 AM

Wells Fargo & Company MN Acquires 7,785 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

06:50 AM

Apr 24, 2025

Geode Capital Management LLC Has $9.42 Million Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Apr 24, 2025

Apr 23, 2025

Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress - ADVFN

Apr 23, 2025

Apr 22, 2025

Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025 - Business Wire

Apr 22, 2025

Apr 22, 2025

Long Term Trading Analysis for (ARCT) - news.stocktradersdaily.com

Apr 22, 2025

Apr 21, 2025

JPMorgan Chase & Co. Has $4.01 Million Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Apr 21, 2025

Apr 20, 2025

Research Analysts Set Expectations for ARCT Q1 Earnings - American Banking and Market News

Apr 20, 2025

Apr 19, 2025

Q1 Earnings Estimate for ARCT Issued By Leerink Partnrs - Defense World

Apr 19, 2025

Apr 18, 2025

European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine (PR Newswire) - Aktiellt

Apr 18, 2025

Apr 15, 2025

Vanguard Group Inc. Grows Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Apr 15, 2025

Apr 14, 2025

Can The Upcoming Catalysts Breathe New Life Into Arcturus Therapeutics? - RTTNews

Apr 14, 2025

Apr 13, 2025

Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate - MSN

Apr 13, 2025

Apr 12, 2025

KLP Kapitalforvaltning AS Acquires New Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Apr 12, 2025

Apr 12, 2025

HC Wainwright Reiterates Buy Rating for Arcturus Therapeutics (NASDAQ:ARCT) - Defense World

Apr 12, 2025

Apr 11, 2025

High Growth Tech Stocks To Watch In The US April 2025 - simplywall.st

Apr 11, 2025

Apr 11, 2025

Arcturus Therapeutics (ARCT) Gains FDA Fast Track for Influenza Vaccine - GuruFocus

Apr 11, 2025

Apr 11, 2025

Arcturus Therapeutics (ARCT) Receives Fast Track Status for Infl - GuruFocus

Apr 11, 2025

Apr 11, 2025

Arcturus Therapeutics Receives U.S. FDA Fast Track Designation f - GuruFocus

Apr 11, 2025

Apr 11, 2025

Guggenheim Lowers Price Target for Arcturus Therapeutics (ARCT) Amid Risk Adjustments | ARCT Stock News - GuruFocus

Apr 11, 2025

Apr 10, 2025

Arcturus wins FDA fast track status for influenza vaccine - MSN

Apr 10, 2025

Apr 10, 2025

Arcturus wins FDA fast track status for flu shot (ARCT:NASDAQ) - Seeking Alpha

Apr 10, 2025

Apr 10, 2025

Arcturus Therapeutics Says FDA Granted Fast Track Designation to Potential H5N1 Vaccine - marketscreener.com

Apr 10, 2025

Apr 10, 2025

Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1 - Business Wire

Apr 10, 2025

Apr 10, 2025

Breakthrough: FDA Fast-Tracks Revolutionary mRNA Vaccine Against Deadly H5N1 Pandemic Flu - Stock Titan

Apr 10, 2025

Apr 09, 2025

Commonwealth Equity Services LLC Reduces Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Apr 09, 2025

Apr 07, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives $59.20 Consensus Price Target from Brokerages - Defense World

Apr 07, 2025

Apr 06, 2025

(ARCT) Investment Report - news.stocktradersdaily.com

Apr 06, 2025

Mar 26, 2025

(ARCT) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Mar 26, 2025

Mar 24, 2025

Bank of New York Mellon Corp Sells 22,024 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Mar 24, 2025

Mar 20, 2025

Is Arcturus Therapeutics (ARCT) a Worst High-Risk High-Reward Growth Stock to Buy? - Insider Monkey

Mar 20, 2025

Mar 20, 2025

Benign Growth For Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Underpins Stock's 26% Plummet - simplywall.st

Mar 20, 2025

Mar 18, 2025

Arcturus up 9% as phase 2 dosing begins for mRNA asset for cystic fibrosis - MSN

Mar 18, 2025

Mar 17, 2025

William Blair Issues Pessimistic Outlook for ARCT Earnings - Defense World

Mar 17, 2025

Mar 16, 2025

(ARCT) Proactive Strategies - news.stocktradersdaily.com

Mar 16, 2025

Mar 13, 2025

Arcturus Therapeutics Holdings Inc to Host Earnings Call - ACCESS Newswire

Mar 13, 2025

Mar 13, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives $61.40 Average PT from Analysts - Defense World

Mar 13, 2025

Mar 12, 2025

Arcturus Therapeutics at Leerink’s Conference: mRNA Innovations and Strategic Plans - Investing.com UK

Mar 12, 2025

Mar 12, 2025

Despite Revenue Setback, Arcturus Therapeutics (ARCT) Vaccine Breakthroughs Fuel Optimism - markets.businessinsider.com

Mar 12, 2025

Mar 11, 2025

Arcturus Therapeutics (NASDAQ:ARCT) Given New $68.00 Price Target at Canaccord Genuity Group - Defense World

Mar 11, 2025

Mar 09, 2025

Analysts Have Lowered Expectations For Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) After Its Latest Results - Simply Wall St

Mar 09, 2025

Mar 09, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo

Mar 09, 2025

Mar 09, 2025

HC Wainwright Lowers Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $60.00 - Defense World

Mar 09, 2025

Mar 09, 2025

Arcturus Therapeutics (NASDAQ:ARCT) Earns Overweight Rating from Cantor Fitzgerald - Defense World

Mar 09, 2025

Mar 08, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 08, 2025

Mar 07, 2025

Arcturus Therapeutics stock hits 52-week low at $14.3 By Investing.com - Investing.com Australia

Mar 07, 2025

Mar 07, 2025

Beyond The Numbers: 8 Analysts Discuss Arcturus Therapeutics Stock - Benzinga

Mar 07, 2025

Mar 07, 2025

Arcturus Therapeutics stock hits 52-week low at $14.3 - Investing.com India

Mar 07, 2025

Mar 07, 2025

Earnings call transcript: Arcturus Therapeutics Q4 2024 misses estimates By Investing.com - Investing.com South Africa

Mar 07, 2025

Mar 07, 2025

Arcturus Therapeutics Reports Q4 2024 Earnings: EPS of ($1.11) M - GuruFocus.com

Mar 07, 2025

Mar 07, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q4 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance

Mar 07, 2025

Mar 07, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q4 2024 Earnings Call - GuruFocus.com

Mar 07, 2025

Mar 07, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q4 2024 Earnings Call Highlights: Navigating ... By GuruFocus - Investing.com Canada

Mar 07, 2025

Mar 06, 2025

Arcturus Therapeutics Reports 2024 Financial Results and Pipeline Progress - TipRanks

Mar 06, 2025

Mar 06, 2025

Arcturus Therapeutics Holdings Inc earnings missed by $0.92, revenue fell short of estimates - Investing.com Canada

Mar 06, 2025